Photo: isbtweb.org
Mar 3, 2026, 14:21
Webinar on CAR-T Cells – Heterogeneity, Quality Control, and Adverse Events – ISBT
International Society of Blood Transfusion (ISBT) shared a post on LinkedIn:
“ISBT Webinar: Let’s talk CAR-T cells – heterogeneity, quality control and adverse events.
4 March 2026 | 17:00–18:00 CET
Join Oulghazi Salim for an accessible introduction to CAR-T cell therapy, covering clinical applications, cellular heterogeneity, quality control advances, and associated adverse events.
Ideal for scientists, transfusion professionals, MDs, and MSc/PhD students.
Register now and be part of the conversation”
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 16:40William Wallace: Vitamin C and Collagen Work as One Biological System
-
Jun 24, 2026, 16:32Arlindo Nascimento de Lemos Junior: Thrombus Echogenicity as a Predictor of Post-Thrombotic Syndrome Severity After DVT
-
Jun 24, 2026, 16:09Jimi Olaghere: The Future of Sickle Cell Disease Research Starts With Collaboration
-
Jun 24, 2026, 16:03Von Willebrand Disease as a Common Yet Under-Recognised Bleeding Disorder – EHC
-
Jun 24, 2026, 15:57Maia Meier: Women with Bleeding Disorders Reach the Summit of Mont Blanc
-
Jun 24, 2026, 15:40Annette Bowyer: The Emerging Role of Extravascular Factor VII in Haemostasis
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss